Amy Mahery
Fortuna: 5 $ al 30/06/2026
Fortuna: 5 $ al 30/06/2026
Ms. Amy Mahery is an Independent Director at CNS Pharmaceuticals, Inc. She is on the Board of Directors at CNS Pharmaceuticals, Inc. Ms. Mahery was previously employed as a Chief Commercial Officer by Roivant Sciences Ltd. and a Senior Vice President by EMD Serono, Inc. She received her undergraduate degree from Trinity College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/04/2026 | 1 ( 0 % ) | 5 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 18/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01/12/2024 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01/07/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.